MarketCapTrends
XFOR

X4 Pharmaceuticals Inc. (XFOR)

NASDAQ · Healthcare

X4 Pharmaceuticals Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • X4 Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 104.2M, a 16.19% decrease year-over-year.
  • X4 Pharmaceuticals Inc. total liabilities for 2025 were 104.2M, a 16.19% decrease from 2024.
  • X4 Pharmaceuticals Inc. total liabilities for 2024 were 124.3M, a 29.26% increase from 2023.
  • X4 Pharmaceuticals Inc. total liabilities for 2023 were 96.2M, a 17.94% increase from 2022.
  • X4 Pharmaceuticals Inc. total liabilities for 2022 were 81.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
X4 Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$104
2024$124
2023$96
2022$82
2021$53
2020$50
2019$31
2018$22
X4 Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$104
2024-12-31$124
2023-12-31$96
2022-12-31$82
2021-12-31$53
2020-12-31$50
2019-12-31$31
2018-12-31$22

X4 Pharmaceuticals Inc. Total Liabilities — FAQ

X4 Pharmaceuticals Inc. (XFOR) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XFOR's total liabilities history?

The chart and table above show X4 Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.